News items related to: News
-
Brazil: Open letter insists that pharmaceuticals’ interests must NOT be prioritized over public health
The Working Group on Intellectual Property responds to what it sees as ‘an attack on the rights of the Brazilian...
-
Victory: Gilead forced to withdraw Truvada® patent application in Argentina
Gilead prevented from obtaining an illegitimate monopoly at the expense of people’s health. Activists in Argentina, including our partner...
-
Ukraine: HIV patients appeal against deadly patent monopoly
Unmerited patents protecting profit not patients – protesting & appealing the decisions so far. 50% of Ukraine’s budget for HIV...
-
Patients and Ministers discuss access to essential medicines in Ukraine
Working together to reform patent law in Ukraine – and new Working Group is founded. Last month (21 April) our...
-
#TreatPeopleRight – Highlights from the ITPC Annual Review
Campaign activity contributing to combined savings of US$700 million for health budgets is among ITPC’s 2016 highlights. The mission of...
-
Infographic: How civil society action led to price reductions in Argentina
Civil society action means 27,000 more people could receive HIV treatment for 10 years. The price of 2 key HIV...
-
I-MAK challenges validity of remaining Hepatitis C drug patent
Legal challenge to unblock Hep C Treatment for up to 13 million people. In a move that could strike down...
-
US-Argentina patent agreement presents public health concern
An alarming unbalanced three-year agreement could result in more unmerited patents in Argentina. As a global coalition of treatment activists...
-
Brazilian Activists: Third-party in a legal case, to prevent weakening of patent system
On April 7, the Working Group on Intellectual Property of the Brazilian Network for the Integration of Peoples (GTPI/Rebrip), filed...
-
Infographics: Who’s benefitting from the abuse of Thailand’s patent system – and how
Our partner, the AIDS Access Foundation in Thailand, has produced a series of infographics, highlighting who is filing for patents...
-
Brazil: People waiting for Hep C cure caught between a life-changing decision – and an attempt to block it
Anvisa’s decision would allow the purchase of generics, and increase access to quality Hep C treatment – but a simultaneous...
-
Advocating for an improved patent applications process in Ukraine
The decision to grant or refuse a patent has an impact on the price of essential medicines – and huge...